Impact of cytoreductive nephretomy on timing of systemic therapy in metastatic kidney cancer.

被引：0
|
作者：
Macleod, Liam Connor
Dash, Atreya
Schade, George
Harper, Jonathan D.
Lin, Daniel W.
Tykodi, Scott S.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
503
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Upfront cytoreductive nephrectomy vs. upfront systemic therapy in metastatic kidney cancer
    Kapoor, Anil
    Wong, Emily C. L.
    Fang, Wayne
    Wong, Nathan C.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (11): : E377 - E381
  • [2] LITMUS TEST OR DESTINATION SYSTEMIC THERAPY? REFERRAL FOR CYTOREDUCTIVE NEPHRECTOMY AFTER INITIAL SYSTEMIC THERAPY IN METASTATIC KIDNEY CANCER
    Macleod, Liam C.
    Dash, Atreya
    Schade, George R.
    Odisho, Anobel Y.
    Tykodi, Scott S.
    Gore, John L.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E187 - E188
  • [3] Utilization and sequencing of targeted therapy and cytoreductive nephrectomy in non-clear cell metastatic kidney cancer.
    Macleod, Liam Connor
    Tykodi, Scott S.
    Holt, Sarah
    Gore, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [4] Litmus test or destination systemic therapy? Trends in referral for surgery after initial systemic therapy in metastatic kidney cancer.
    Macleod, Liam Connor
    Dash, Atreya
    Schade, George
    Tykodi, Scott S.
    Gore, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [5] Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer
    Siech, Carolin
    de Angelis, Mario
    Jannello, Letizia Maria Ippolita
    Di Bello, Francesco
    Penaranda, Natali Rodriguez
    Goyal, Jordan A.
    Tian, Zhe
    Saad, Fred
    Shariat, Shahrokh F.
    Puliatti, Stefano
    Longo, Nicola
    de Cobelli, Ottavio
    Briganti, Alberto
    Hoeh, Benedikt
    Mandel, Philipp
    Kluth, Luis A.
    Chun, Felix K. H.
    Karakiewicz, Pierre I.
    CRITICAL CARE MEDICINE, 2025, 53 (01) : e132 - e139
  • [6] Underutilization of best systemic therapy in patients with metastatic prostate cancer.
    Roadman, Daniel
    Cao, David
    Vourganti, Srinivas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Impact of systemic inflammation and sarcopenia on prognosis of metastatic colorectal cancer.
    da Silva Dias, David
    Machado, Mafalda
    Gosalbez, Beatriz
    Ravasco, Paula
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [8] Utilization of systemic therapy options in the routine treatment of metastatic colorectal cancer.
    Delahunty, Rachel Lee
    Lee, Margaret
    Wong, Hui-Li
    McKendrick, Joseph James
    Lee, Belinda
    Kosmider, Suzanne
    Cooray, Prasad
    Ananda, Sumitra
    Tran, Ben
    Tie, Jeanne
    Desai, Jayesh
    Gibbs, Peter
    Wong, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [9] CYTOREDUCTIVE SURGERY FOR METASTATIC TESTIS CANCER - CONSIDERATIONS OF TIMING AND EXTENT
    DONOHUE, JP
    EINHORN, LH
    WILLIAMS, SD
    JOURNAL OF UROLOGY, 1980, 123 (06): : 876 - 880
  • [10] Prognostic impact of systemic therapy change in metastatic renal cell carcinoma treated with cytoreductive nephrectomy
    Ishihara, Hiroki
    Takagi, Toshio
    Kondo, Tsunenori
    Fukuda, Hironori
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kobayashi, Hirohito
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (02) : 296 - 304
12345